Latest news
Loading news…
Karuna Therapeutics is a biopharmaceutical company that develops and delivers medicines for psychiatric and neurological conditions.
Karuna Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Karuna Therapeutics was acquired by Bristol-Myers Squibb in 2023 for $14B.
Total Funding
$1.55B
Funding Rounds
6
Last Funding
Acquisitions
0
Monthly Visits
Contacts
150
About Karuna Therapeutics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- Boston, Massachusetts, United States
Karuna Therapeutics Funding Rounds
6 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–5 of 6Show
Page 1 / 2
Karuna Therapeutics Key People
CMO
Vice President of Legal Affairs
Clinical Development, Senior Vice President Clinical Operations
Vice President of Medical
150
professional contacts at Karuna Therapeutics
Contact execs at Karuna Therapeutics →Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
FAQs about Karuna Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.